A viral infectious disease emerged at the end of 2019, and it rapidly spread over the globe. The pandemic's global impact is scary, and it may not have reached its apex yet. The human race is likewise in a state of crisis as a result of mandatory quarantines and lockdowns. Nanoparticles (NPs) and viruses have similar scales of activity, making nanotechnology a powerful tool for vaccine development and immunoengineering. Researchers in the field of nanomedicine have been constantly investigating the relationship between the ability of various nano systems and viral vectors to deliver genes and high infectivity. Nanotechnology could be the safest alternative to novel vaccine development technologies since NPs can replicate the structural and functional properties of viruses. Two nanoparticle-based vaccinations on the verge of being approved by the US Food and Drug Administration could be a game-changer in the fight against the COVID-19 pandemic. If they succeed, they will contribute to the mitigation of a global health catastrophe of unprecedented dimensions in modern history, illustrating the worldwide effect of nanomedicine and spreading awareness about its potential advantages to the broadest possible audience.
Title : Safety management for nanomaterials in research environments
Thierry Meyer, EPFL, Switzerland
Title : Nanotransporters for the release of bioactive molecules
Antonio Vassallo, University of Basilicata, Italy
Title : Artificial intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, United States
Title : Interaction between actin and quantum dots
Kyoungtae Kim, Missouri State University, United States
Title : Laser welded carbon nanotubes graphene hybrid structures: Modeling, formation, application
Olga E Glukhova, Saratov State University, Russian Federation
Title : Introducing nanoporous metallic capsules for improved stem cell delivery and function
Thomas J Webster, Hebei University of Technology, China